News

Registry data provide no evidence of stroke mortality ‘obesity paradox’


 

FROM JAMA NEUROLOGY

Some studies have suggested that overweight and obese patients have a survival advantage following stroke, but no evidence of this "obesity paradox" was found in an analysis of registry data.

Of 71,617 patients in the Danish Stroke Register, 7,878 (11%) died within a month of the index stroke, with 5,512 of the deaths (70%) attributable to the stroke. The largest proportion of deaths (39%) were among normal-weight patients, while 9.7% were underweight, 34.5% were overweight, and 16.8% were obese. The hazard ratios for stroke mortality for overweight and obese patients, compared with normal weight patients, were 0.96 and 1.0, respectively, Christian Dehlendorff, Ph.D., of the Danish Cancer Society Research Center, Copenhagen, and associates reported online June 2 in JAMA Neurology.

Of note, BMI was inversely related to average age of stroke onset, the investigators found (JAMA Neurol. 2014 June 2 [doi:10.1001/jamaneurol.2014.1017]).

The findings suggest that the "obesity paradox" identified in some earlier studies was an artifact related to selection bias, and that overweight and obese individuals with stroke should continue to aim for normal weight, the investigators concluded.

This study was funded by Jascha Foundation. The authors reported having no disclosures.

Recommended Reading

Manual aspiration removes blood clots in more than half of ischemic stroke patients
MDedge Internal Medicine
Insertable monitor reveals AF in 30% of cryptogenic stroke patients
MDedge Internal Medicine
Telemedicine gives small hospitals the biggest boost in rTPA use for stroke
MDedge Internal Medicine
Emergency thrombolysis by presumed consent preferred in majority of older adults
MDedge Internal Medicine
OA-related walking disability on par with diabetes as CVD risk factor
MDedge Internal Medicine
Coronary artery calcification can guide aspirin therapy
MDedge Internal Medicine
INR test strips recalled due to reports of inaccurate results
MDedge Internal Medicine
UPDATED: FDA-released safety data on dabigatran vs. warfarin reassuring
MDedge Internal Medicine
RKV/BSA ratio predicted decline of renal function after radical nephrectomy
MDedge Internal Medicine
Registry renal denervation skews from resistant hypertension
MDedge Internal Medicine